Bio Essence Corp

The company is incorporated in California and operates from the United States, with its functional currency reported as U.S. dollars. The filings do not provide a country-by-country revenue split, so the geographic profile cannot be quantified from the available excerpts. Operationally, the business has been centered on California subsidiaries and U.S.-based corporate structure, including prior manufacturing and distribution entities. Because the company now outsources manufacturing/OEM work, its geographic exposure is less about owned plants and more about where customers and third-party service providers are located. The lack of disclosed international revenue detail limits visibility into cross-border demand or supply-chain concentration.

The most immediate company-specific risk is going-concern uncertainty, driven by recurring losses and a large accumulated deficit. Revenue is concentrated in OEM service activity, so the business is exposed to customer order volatility, customer concentration, and the loss or delay of large contracts. Because the company now outsources manufacturing, it also depends on third parties for execution quality, timing, and cost control, which can pressure margins and service reliability. More broadly, supplement and contract manufacturing businesses face regulatory, quality, and demand risks, including changing consumer preferences and competition from larger, better-capitalized operators. Financing risk is also material because the company may need external capital to sustain operations and fund growth initiatives.